Enhancement of regeneration with glia cell line-derived neurotrophic factor-transduced human amniotic fluid mesenchymal stem cells after sciatic nerve crush injury.

OBJECT Human amniotic fluid-derived mesenchymal stem cells (AFMSCs) have been shown to promote peripheral nerve regeneration, and the local delivery of neurotrophic factors may additionally enhance nerve regeneration capacity. The present study evaluates whether the transplantation of glia cell line-derived neurotrophic factor (GDNF)-modified human AFMSCs may enhance regeneration of sciatic nerve after a crush injury. METHODS Peripheral nerve injury was produced in Sprague-Dawley rats by crushing the left sciatic nerve using a vessel clamp. Either GDNF-modified human AFMSCs or human AFMSCs were embedded in Matrigel and delivered to the injured nerve. Motor function and electrophysiological studies were conducted after 1 and 4 weeks. Early or later nerve regeneration markers were used to evaluate nerve regeneration. The expression of GDNF in the transplanted human AFMSCs and GDNF-modified human AFMSCs was monitored at 7-day intervals. RESULTS Human AFMSCs were successfully transfected with adenovirus, and a significant amount of GDNF was detected in human AFMSCs or the culture medium supernatant. Increases in the sciatic nerve function index, the compound muscle action potential ratio, conduction latency, and muscle weight were found in the groups treated with human AFMSCs or GDNF-modified human AFMSCs. Importantly, the GDNF-modified human AFMSCs induced the greatest improvement. Expression of markers of early nerve regeneration, such as increased expression of neurofilament and BrdU and reduced Schwann cell apoptosis, as well as late regeneration markers, consisting of reduced vacuole counts, increased expression of Luxol fast blue and S100 protein, paralleled the results of motor function. The expression of GDNF in GDNF-modified human AFMSCs was demonstrated up to 4 weeks; however, the expression decreased over time. CONCLUSIONS The GDNF-modified human AFMSCs appeared to promote nerve regeneration. The consecutive expression of GDNF was demonstrated in GDNF-modified human AFMSCs up to 4 weeks. These findings support a nerve regeneration scenario involving cell transplantation with additional neurotrophic factor secretion.

[1]  A. Milunsky.  Amniotic Fluid Cell Culture , 1979 .

[2]  Patrick Aebischer,et al.  Glial cell line‐derived neurotrophic factor released by synthetic guidance channels promotes facial nerve regeneration in the rat , 2002, Journal of neuroscience research.

[3]  J. Widenfalk,et al.  Repair of peripheral nerve transections with fibrin sealant containing neurotrophic factors , 2003, Experimental Neurology.

[4]  M. Papaloïzos,et al.  Variations in glial cell line‐derived neurotrophic factor release from biodegradable nerve conduits modify the rate of functional motor recovery after rat primary nerve repairs , 2007, The European journal of neuroscience.

[5]  A. Blesch,et al.  Nerve growth factor–hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1 , 1999, The Journal of comparative neurology.

[6]  Shiaw-Min Hwang,et al.  Combination of G-CSF Administration and Human Amniotic Fluid Mesenchymal Stem Cell Transplantation Promotes Peripheral Nerve Regeneration , 2009, Neurochemical Research.

[7]  Peter Gais,et al.  GDNF-transduced Schwann cell grafts enhance regeneration of erectile nerves. , 2008, European urology.

[8]  Q. Yan,et al.  In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons , 1995, Nature.

[9]  A. Davies,et al.  GDNF is an age-specific survival factor for sensory and autonomic neurons , 1995, Neuron.

[10]  B. Hontanilla,et al.  Local administration of neurotrophic growth factor in subcutaneous silicon chambers enhances the regeneration of the sensory component of the rat sciatic nerve , 1999, Microsurgery.

[11]  R. Vejsada,et al.  Synergistic but transient rescue effects of BDNF and GDNF on axotomized neonatal motoneurons , 1998, Neuroscience.

[12]  P. Melo-Pinto,et al.  Functional and morphological assessment of a standardized rat sciatic nerve crush injury with a non-serrated clamp. , 2004, Journal of neurotrauma.

[13]  Pedro Melo-Pinto,et al.  Methods for the experimental functional assessment of rat sciatic nerve regeneration , 2004, Neurological research.

[14]  M. Tsai,et al.  Clonal Amniotic Fluid-Derived Stem Cells Express Characteristics of Both Mesenchymal and Neural Stem Cells1 , 2006, Biology of reproduction.

[15]  R. Oppenheim,et al.  Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF , 1995, Nature.

[16]  M. Tuszynski,et al.  Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression , 2001, Gene Therapy.

[17]  M. Ochi,et al.  Transplanted neuronal progenitor cells in a peripheral nerve gap promote nerve repair , 2003, Brain Research.

[18]  Shiaw-Min Hwang,et al.  Human Amniotic Fluid Mesenchymal Stem Cells in Combination with Hyperbaric Oxygen Augment Peripheral Nerve Regeneration , 2009, Neurochemical Research.

[19]  Masahiko Takano,et al.  Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone‐marrow stromal cells , 2001, The European journal of neuroscience.

[20]  A. Bader,et al.  Viability of cultured nerve grafts: An assessment of proliferation of Schwann cells and fibroblasts , 1999, Microsurgery.

[21]  S. Ho,et al.  Post-injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells , 2007, Journal of Clinical Neuroscience.

[22]  J. Kuo,et al.  Gene transfer of glial cell line-derived neurotrophic factor promotes functional recovery following spinal cord contusion , 2003, Experimental Neurology.

[23]  A. Awaya,et al.  Basic Behavior of Migratory Schwann Cells in Peripheral Nerve Regeneration , 1996, Experimental Neurology.

[24]  T. Hökfelt,et al.  GDNF mRNA in Schwann cells and DRG satellite cells after chronic sciatic nerve injury , 1996, Neuroreport.

[25]  Q. Yan,et al.  Glial cell line-derived neurotrophic factor (GDNF) promotes the survival of axotomized retinal ganglion cells in adult rats: comparison to and combination with brain-derived neurotrophic factor (BDNF). , 1999, Journal of neurobiology.

[26]  T. Crawford,et al.  Glial Cell Line-Derived Neurotrophic Factor Alters Axon Schwann Cell Units and Promotes Myelination in Unmyelinated Nerve Fibers , 2003, The Journal of Neuroscience.

[27]  C. Giraud,et al.  Adenovirus and Adeno‐Associated Virus as Vectors for Gene Therapy a , 1995, Annals of the New York Academy of Sciences.

[28]  T. Gordon,et al.  Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury , 2003, Molecular Neurobiology.

[29]  G. Pizzolo,et al.  Regenerative and immunomodulatory potential of mesenchymal stem cells. , 2006, Current opinion in pharmacology.

[30]  S. Whittemore,et al.  Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord , 1998, The European journal of neuroscience.

[31]  T. Omura,et al.  The recovery of blood–nerve barrier in crush nerve injury—a quantitative analysis utilizing immunohistochemistry , 2004, Brain Research.

[32]  Andrea-Romana Prusa,et al.  Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? , 2003, Human reproduction.

[33]  J. R. Hoffman,et al.  Nerve growth factor and neurotrophin-3 affect functional recovery following peripheral nerve injury differently. , 2001, Restorative neurology and neuroscience.

[34]  Patrick Aebischer,et al.  GDNF and NGF released by synthetic guidance channels support sciatic nerve regeneration across a long gap , 2002, The European journal of neuroscience.

[35]  W. Freed,et al.  An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks , 1982, Experimental Neurology.

[36]  M. Tuszynski,et al.  Grafts of genetically modified Schwann cells to the spinal cord: survival, axon growth, and myelination. , 1998, Cell transplantation.

[37]  T. Kilpatrick,et al.  Induction of Postnatal Schwann Cell Death by the Low-Affinity Neurotrophin Receptor In Vitro and after Axotomy , 2000, The Journal of Neuroscience.

[38]  W. ElShamy,et al.  Differential Regulation of mRNAs for GDNF and its Receptors Ret and GDNFRα After Sciatic Nerve Lesion in the Mouse , 1997, The European journal of neuroscience.

[39]  F. Claas,et al.  Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. , 2003, Blood.

[40]  Cheng He,et al.  Glial cell line-derived neurotrophic factor enhances axonal regeneration following sciatic nerve transection in adult rats , 2001, Brain Research.

[41]  Ramza S Shahid,et al.  Preparation of brain-derived neurotrophic factor-and neurotrophin-3-secreting schwann cells by infection with a retroviral vector , 1998, Journal of Molecular Neuroscience.

[42]  M. Ruitenberg,et al.  Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. , 2004, Progress in brain research.

[43]  N. Belluardo,et al.  Complementary and Overlapping Expression of Glial Cell Line-Derived Neurotrophic Factor (GDNF), c-ret Proto-Oncogene, and GDNF Receptor-α Indicates Multiple Mechanisms of Trophic Actions in the Adult Rat CNS , 1997, The Journal of Neuroscience.

[44]  R. Oppenheim,et al.  Effects of neurotrophic factors on motoneuron survival following axonal injury in newborn rats , 2000, Neuroreport.

[45]  G. Terenghi,et al.  Effects of delayed re‐innervation on the expression of c‐erbB receptors by chronically denervated rat Schwann cells in vivo , 1997, Glia.

[46]  C. Henderson,et al.  GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. , 1994, Science.

[47]  M. Tuszynski,et al.  Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination , 2003, The Journal of comparative neurology.

[48]  G. Dewald,et al.  Pseudomosaicism, true mosaicism, and maternal cell contamination in amniotic fluid processed with in situ culture and robotic harvesting , 1992, Prenatal diagnosis.

[49]  D. Alessi,et al.  S100 is preferentially distributed in myelin-forming Schwann cells , 1990, Journal of neurocytology.

[50]  Dar-Yu Yang,et al.  Enhanced regeneration in injured sciatic nerve by human amniotic mesenchymal stem cell , 2006, Journal of Clinical Neuroscience.